tiprankstipranks
Trending News
More News >
Keros Therapeutics, Inc. (KROS)
:KROS
US Market
Advertisement

Keros Therapeutics (KROS) Ownership - Who Owns Keros Therapeutics?

Compare
346 Followers

Keros Therapeutics (KROS) Ownership Overview

40.88%12.48%0.25%12.75%33.64%
40.88% Insiders
0.25% Other Institutional Investors
12.75% ETFs
33.64% Public Companies and
Individual Investors
The ownership structure of Keros Therapeutics (KROS) stock is a mix of institutional, retail, and individual investors. Approximately 25.47% of the company’s stock is owned by Institutional Investors, 40.88% is owned by Insiders, and 33.64% is owned by Public Companies and Individual Investors.
The ownership structure of Keros Therapeutics (KROS) stock is a mix of institutional, retail, and individual investors. Approximately 12.73% of the company’s stock is owned by Institutional Investors, 40.88% is owned by Insiders, and 12.75% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 24, 2025
xxxxxxxxxxxxx
$118000
Apr 11, 2025
xxxxxxxxxxxxx
$9462056
Aug 15, 2024
xxxxxxxxxxxxx
$11002500
Aug 15, 2024
xxxxxxxxxxxxx
$11002500

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$365566
Mar 31, 2025
xxxxxxxxxxxxx
$1374773

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,134,595Insider12.64%73,732,784
4,637,319Insider11.42%66,591,901
4,637,319Insider11.42%66,591,901
1,913,200Institution4.71%27,473,552
1,593,944Institution3.92%22,889,036
1,467,685Institution3.61%21,075,957
1,023,984Insider2.52%14,704,410
934,054Institution2.30%13,413,015
753,557Institution1.86%10,821,079
580,742Insider1.43%8,339,455

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,593,944Institution3.92%22,889,036
934,054Institution2.30%13,413,015
377,478Institution0.93%5,420,584
368,541Institution0.91%5,292,249
363,205Institution0.89%5,215,624
347,118Institution0.85%4,984,614
170,109Institution0.42%2,442,765
115,812Institution0.29%1,663,060
111,700Institution0.28%1,604,012
95,461Institution0.24%1,370,820

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,092,345Institution2.69%14,582,806
854,286Institution2.10%12,267,547
631,242Institution1.55%9,146,697
548,134Institution1.35%7,317,589
323,562Institution0.80%4,688,413
289,169Institution0.71%4,152,467
207,077Institution0.51%2,973,626
171,905Institution0.42%2,294,932
161,603Institution0.40%2,341,627
145,447Institution0.36%2,107,527

FAQ

Who Owns Keros Therapeutics, Inc. (KROS)?
According to the latest TipRanks data, approximately 0.25% of the company's stock is held by institutional investors, 40.88% is held by insiders, and 33.64% is held by retail investors.
    What percentage of Keros Therapeutics, Inc. (KROS) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.25% of Keros Therapeutics, Inc. (KROS) stock is held by institutional investors.
      What percentage of Keros Therapeutics, Inc. (KROS) stock is held by retail investors?
      According to the latest TipRanks data, approximately 33.64% of Keros Therapeutics, Inc. (KROS) stock is held by retail investors.
        Who owns the most shares of Keros Therapeutics, Inc. (KROS)?
        ADAR1 Capital Management, LLC owns the most shares of Keros Therapeutics, Inc. (KROS).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis